The Importance of Hit to Lead Services in Early-Stage Drug Discovery
Early-stage drug discovery is a critical phase that determines whether a potential therapy will ultimately succeed or fail. After initial screening identifies biologically active compounds, researchers face the challenge of transforming those early hits into viable drug candidates. This transition is complex, resource-intensive, and scientifically demanding. Hit to lead services play a central role in…
